Decreased IgE Activity [PE] - N0000175793

Pharmacologic Code	N0000175793
Pharmacologic Name	Decreased IgE Activity
Pharmacologic Uses	anti-IgE
Pharmacologic Concept	Physiologic Effects - [PE]
Pharmacologic Concept Description	This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Decreased IgE Activity [PE].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	50242-040	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-214	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-215	Xolair Pfs	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE
	50242-227	Xolair	Non-Proprietary Name: Omalizumab	Injection, Solution	Subcutaneous	Genentech, Inc.	ACTIVE